LIFECORE BIOMEDICAL INC DE
For the period ended May 25, 2025. Filed Aug 7, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Aug 7, 2025
LFCR$6.370.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 15. Exhibits and financial statement chedules
Item 15. Exhibits and financial statement schedules
(a)
| Page | ||
|---|---|---|
| 1. · Consolidated financial statements of Lifecore Biomedical, Inc. | ||
| Reports of Independent Registered Public Accounting Firm (BDO USA, P.C., PCAOB ID: 243) | 48 | |
| Consolidated Balance Sheets at May 25, 2025 and May 26, 2024 | 51 | |
| Consolidated Statements of Operations for the Years Ended May 25, 2025 and May 26, 2024 | 52 | |
| Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) for the Years Ended May 25, 2025 and May 26, 2024 | 53 | |
| Consolidated Statements of Cash Flows for the Years Ended May 25, 2025 and May 26, 2024 | 54 | |
| Notes to Consolidated Financial Statements | 55 | |
| 2. | All schedules provided for in the applicable accounting regulations of the Securities and Exchange Commission have been omitted since they pertain to items which do not appear in the financial statements of Lifecore and its subsidiaries or to items which are not significant or to items as to which the required disclosures have been made elsewhere in the financial statements and supplementary notes and such schedules. | |
| 3. | Index of exhibits | 42 |
| The exhibits listed in the accompanying Index of Exhibits are filed or incorporated by reference as part of this report. | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.